Report Categories
View AllRecent Articles
View All
Dianthus Therapeutics Q1 2026 Earnings EPS Beat Amid PreRevenue Stage
MAA Q1 2026 Earnings Strong EPS Surprise of 31 Amid Mixed Revenue Visibility
PANW Q1 2026 Earnings Strong EPS Beat Drives Positive Stock Reaction
ConAgra Brands CAG Q1 2026 Earnings EPS Misses Estimates Despite Modest Stock Gain
Estrella Immunopharma ESLA Q1 2026 Earnings WiderThanExpected Loss Triggers Modest Stock Gain